BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20299489)

  • 1. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
    Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
    Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
    Shelly C; Petruzzelli L; Herrera R
    Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.
    Eriksson M; Arminen L; Karjalainen-Lindsberg ML; Leppä S
    Exp Cell Res; 2005 Mar; 304(1):175-86. PubMed ID: 15707584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
    Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
    Lee CH; Yun HJ; Kang HS; Kim HD
    IUBMB Life; 1999 Dec; 48(6):585-91. PubMed ID: 10683762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling mechanism of PMA-induced differentiation of K562 cells.
    Kang CD; Lee BK; Kim KW; Kim CM; Kim SH; Chung BS
    Biochem Biophys Res Commun; 1996 Apr; 221(1):95-100. PubMed ID: 8660351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible expression of the megakaryocyte-specific gene glycoprotein IX is mediated through an Ets binding site and involves upstream activation of extracellular signal-regulated kinase.
    Eisbacher M; Khachigian LM; Khin TH; Holmes ML; Chong BH
    Cell Growth Differ; 2001 Aug; 12(8):435-45. PubMed ID: 11504709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
    Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
    Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
    Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
    Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
    Pettiford SM; Herbst R
    Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the potential target genes of microRNA-146a induced by PMA treatment in human microvascular endothelial cells.
    Hsieh CH; Rau CS; Jeng SF; Lin CJ; Chen YC; Wu CJ; Lu TH; Lu CH; Chang WN
    Exp Cell Res; 2010 Apr; 316(7):1119-26. PubMed ID: 19944095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
    Tonetti DA; Horio M; Collart FR; Huberman E
    Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase.
    Wang D; Li H; Yuan H; Zheng M; Bai C; Chen L; Pei X
    Apoptosis; 2005 Oct; 10(5):963-71. PubMed ID: 16151632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.